Following sharp criticism from medical professionals regarding the wearable device Temple, startup founder and former Eternal CEO Deepinder Goyal spoke out on Friday to clarify that the gadget functions strictly as a fitness tracker and wellness device. He assured the public that rigorous scientific validation and independent studies will be shared as soon as the product reaches users.
In a series of posts on the social media platform X, Goyal explained that customers will be able to test the device's claims firsthand once it is delivered. He highlighted that the company has instituted a 14-day return policy, allowing users to return the device without any questions asked if they are unsatisfied.
Detailing the financial backing behind the project, he noted that Temple has consumed an investment of approximately 30 million dollars, which includes nearly 20 million dollars of his own capital. He argued that such a substantial financial stake and long-term commitment completely invalidate any suggestions that the product is fraudulent.
Goyal stepped down from his role as Eternal's CEO specifically to focus on Temple, emphasizing that his personal reputation is directly tied to the scientific accuracy behind the product.
He candidly admitted that Temple has not yet completed the clinical verification for all of its metrics, adding that the company will release this information as soon as such verification becomes officially available.
Fitness Tracker Versus Medical Device
Reiterating the device's core purpose, Goyal stated that Temple is a fitness tracker and wellness device rather than a medical tool. He added that further scientific validation and independent studies will emerge as the product becomes widely accessible to users.
These remarks follow a wave of growing criticism from medical experts, most notably led by hepatologist Cyriac Abby Philips, widely known online as The Liver Doc.
Philips has publicly challenged the scientific validity of Temple, specifically questioning its ability to measure brain-related metrics through the superficial temporal artery. In multiple posts on X, Philips alleged that the company has failed to provide sufficient evidence supporting its claims regarding cerebral blood flow and other complex physiological parameters.
He argued that the currently available public materials and pre-print research papers fall short of fully substantiating the device's capabilities, accusing the firm of exaggerating the science behind its product.
The Broader Debate Over Scientific Evidence
Critics maintain that independent peer-reviewed evidence must be presented before such health-related claims can be accepted by the public. They argue that consumer wellness gadgets require stringent validation standards.
In response, Goyal maintained that Temple will continue publishing its validation data moving forward and stands firmly behind its scientific methodology. This ongoing discourse has sparked a major online debate regarding the exact level of scientific proof consumer wellness gadgets should provide before making health claims.
